Unknown

Dataset Information

0

The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses.


ABSTRACT: : Hepatitis C virus (HCV) infects ~71 million people worldwide, and 399,000 people die annually due to HCV-related liver cirrhosis and hepatocellular carcinoma. The use of direct-acting antivirals results in a sustained virologic response in >95% of patients with chronic HCV infection. However, several issues remain to be solved to eradicate HCV. At the 26th International Symposium on Hepatitis C Virus and Related Viruses (HCV2019) held in Seoul, South Korea, October 5-8, 2019, virologists, immunologists, and clinical scientists discussed these remaining issues and how we can achieve the elimination of HCV.

SUBMITTER: Shin EC 

PROVIDER: S-EPMC7150740 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications


<b>:</b> Hepatitis C virus (HCV) infects ~71 million people worldwide, and 399,000 people die annually due to HCV-related liver cirrhosis and hepatocellular carcinoma. The use of direct-acting antivirals results in a sustained virologic response in >95% of patients with chronic HCV infection. However, several issues remain to be solved to eradicate HCV. At the 26th International Symposium on Hepatitis C Virus and Related Viruses (HCV2019) held in Seoul, South Korea, October 5-8, 2019, virologist  ...[more]

Similar Datasets

| S-EPMC7169709 | biostudies-literature
| S-EPMC4724642 | biostudies-literature
| S-EPMC9329817 | biostudies-literature
| S-EPMC5831331 | biostudies-literature
| S-EPMC5088011 | biostudies-literature
| S-EPMC7525545 | biostudies-literature
| S-EPMC7438019 | biostudies-literature
| S-EPMC10268394 | biostudies-literature
| S-EPMC10701137 | biostudies-literature